Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04672239 · ClinicalTrials.gov registry record · NA
A Proof-of-concept RCT of Version 3.0 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 229
- Enrollment target
NCT04672239: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04672239 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 229 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04672239, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
Study Summary
This is the third study in a series of 3 studies to develop a smartphone app to support nondaily smokers in quitting smoking, as funded by the American Cancer Society grant #RSG CPPB - 130323 (project dates: 07/01/2017 - 6/30/2021). Study 1 (2017P001106) demonstrated feasibility and acceptability when smokers were onboarded in person. Study 2 (2018P002699) demonstrated feasibility and acceptability when smokers were onboarded remotely, nationwide. The present study is Study 3. It is a 3-group proof-of-concept RCT, in which we seek to test if our app (i.e., Version 3 of our developed smartphone app, called 'Smiling instead of Smoking' (SiS)) is superior to treatment as usual (i.e., TAU) and superior to a control app (i.e., the National Cancer Institute's smartphone app "QuitGuide" (QG).
Interventions
- BEHAVIORAL Smartphone app "Smiling instead of Smoking" (SiS) Version 3
- BEHAVIORAL Smartphone app "QuitGuide" (QG)
- BEHAVIORAL Brochure "Clearing the Air" (CTA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2021-01-28 |
| Est. Completion | 2023-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04672239
The ClinicalTrials.gov registry entry for NCT04672239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Smartphone app "Smiling instead of Smoking" (SiS) Version 3 is the first listed.
NCT04672239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04672239 about?
NCT04672239 is a clinical study titled "A Proof-of-concept RCT of Version 3.0 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)". This is the third study in a series of 3 studies to develop a smartphone app to support nondaily smokers in quitting smoking, as funded by the American Cancer Society grant #RSG CPPB - 130323 (project dates: 07/01/2017 - 6/30/2021). Study 1 (2017P001106) demonstrated feasibility and acceptability wh...
What is the current status of trial NCT04672239?
This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2021-01-28. Estimated completion is 2023-01-06.
What interventions are being tested in trial NCT04672239?
The interventions under investigation include: Smartphone app "Smiling instead of Smoking" (SiS) Version 3 (BEHAVIORAL), Smartphone app "QuitGuide" (QG) (BEHAVIORAL), Brochure "Clearing the Air" (CTA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04672239?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.